Apolipoprotein E and the CNS response to injury

Journal of Cerebral Blood Flow and Metabolism

Volumn 18, Issue 5, 1998, Pages 465-471

  Laskowitz, Daniel T ^a   Horsburgh, Karen ^b   Roses, Allen D ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Apolipoprotein E; Cerebral injury; Stroke; Transgenic mice

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN E; CHOLESTEROL; IMMUNOMODULATING AGENT; NEUROTROPHIC FACTOR;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BRAIN INJURY; CHOLESTEROL METABOLISM; DISEASE ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IMMUNOMODULATION; NEUROBIOLOGY; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031946960     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199805000-00001     Document Type: Review

References (80)

1. Aamar S, Saada A. Rotshenker S (1992) Lesion-induced changes in the production of newly synthesized and secreted apo-E and other molecules are independent of the concomitant recruitment of blood-borne macrophages into injured peripheral nerves. J Neurochem 59:1287-1292
2. Aisen PS (1996) Inflammation and Alzheimer disease. Mol Chem Neuropathol 28:83-88
3. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD (1995) ApoE genotype and survival from intracerebral haemorrhage. Lancet 346:575
4. Ali SM, Dunn E, Oostveen JA, Hall ED, Carter DB (1996) Induction of apolipoprotein E mRNA in the hippocampus of the gerbil after transient global ischemia. Brain Res Mol Brain Res 38:37-44
5. Arvin B, Neville LF, Barone FC, Feuerstein GZ (1996) The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 20:445-452
6. Avila EM, Holdsworth G, Sasaki N, Jackson RL, Harmony JA (1982) Apoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells. J Biol Chem 257:5900-5909
7. Barger SW, Harmon RE (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388:878-881
8. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, Winblad B, Viitanen M (1996) Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 27:1310-1315
9. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE (1995) Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 270:27063-27071
10. Benzing WC, Mufson EJ (1995) Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease. Exp Neurol 132:162-171
11. Borowicz LM, Goldsborough MA, Selnes OA, McKhann GM (1996) Neuropsychologic change after cardiac surgery: a critical review. J Cardiothorac Vasc Anesth 10:105-111
12. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501-1513
13. Bruggemans EF, Van Dijk JG, Huysmans HA (1995) Residual cognitive dysfunctioning at 6 months following coronary artery bypass graft surgery. Eur J Cardiothorac Surg 9:636-643
14. Couderc R, Mahieux F. Bailleul S, Fenelon G, Mary R, Fermanian J (1993) Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke 24:661-664
15. Curtiss LK, Edgington TS (1978) Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. J Clin Invest 61:1298-1308
16. Curtiss LK, Edgington TS (1981) The biologic activity of the immunoregulatory lipoprotein, LDL-In, is independent of its free fatty acid content. J Immunol 126:1382-1386
17. Edgington TS, Curtiss LK (1981) Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response. Cancer Res 41:3786-3788
18. Fleming LM, Weisgraber KH, Strittmatter WJ, Troncoso JC, Johnson GV (1996) Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins. Exp Neurol 138:252-260
19. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B (1994) Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol 145:526-530
20. Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, del Zoppo GJ (1994) Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat). Am J Pathol 144:188-199
21. Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, Kase CS, Pessin MS (1996) Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27:1333-1337
22. Gutman CR, Strittmatter WJ, Weisgraber KH, Matthew WD (1997) Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. J Neurosci 17:6114-6121
23. Hall ED, Oostveen JA, Dunn E, Carter DB (1995) Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Exp Neurol 135:17-27
24. Han SH, Hulette C, Saunders AM, Einstein G, Pericak-Vance M, Strittmatter WJ, Roses AD, Schmechel DE (1994a) Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 128: 13-26
25. Han SH, Einstein G, Weisgraber KH, Strittmatter WJ, Saunders AM, Pericak-Vance M, Roses AD, Schmechel DE (1994b) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J Neuropathol Exp Neurol 53:535-544
26. Hayek T, Oiknine J, Brook JG, Aviram M (1994) Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun 201:1567-1574
27. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc Natl Acad Sci USA 92:9480-9484
28. Horsburgh K, Nicoll JAR (1996a) Selective alterations in the cellular distribution of apolipoprotein E immunoreactivity following transient cerebral ischaemia in the rat. Neuropathol Appl Neurobiol 22:342-349
29. Horsburgh K, Nicoll JAR (1996b) Selective cellular alterations in amyloid precursor protein and apolipoprotein E following transient global ischaemia in the rat. Alzheimer Res 2:37-42
30. Horsburgh K, Graham DI, Nicoll JAR (1997a) Apolipoprotein E immunoreactivity is markedly increased in human hippocampal neurons following cardiorespiratory arrest (Abstr). Soc Neurosci Abs 847.8
31. Horsburgh K, Cole GC. Yang F, Savage MJ, Greenberg MD, Gentleman SM, Graham DI, Nicoll JA (1997b) (Ab)42(43), Ab42, Ab(40) and apoE immunostaining of plaques in fatal head injury (Abstr). 4th International Neurotrauma Symposium, August 23-28, 1997, P 1-12
32. Horsurgh K, Fitzpatrick M, Nilsen M, Nicoll JAR (1997c) Marked alterations in the cellular localisation and levels of apolipoprotein E following acute subdural hematoma in rat. Brain Res 763:103-110.
33. Huang DY, Weisgraber KH, Strittmatter WJ, Matthew WD (1995) Interaction of apolipoprotein E with laminin increases neuronal adhesion and alters neurite morphology. Exp Neurol 136:251-257
34. Hui DY, Harmony JA, Innerarity TL, Mahley RW (1980) Immunoregulatory plasma lipoproteins: role of apoprotein E and apoprotein B. J Biol Chem 255:11,775-11,781
35. Ignatius MJ, Gebicke-Harter PJ, Skene JH, Schilling JW, Weisgraber KH, Mahley RW, Shooter EM (1986) Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 83:1125-1129
36. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S (1997) Apolipoprotein E epsilon-4 associated with chronic traumatic brain injury in boxing. JAMA 278:136-140
37. Kida E, Pluta R, Lossinsky AS, Golabeck AA, Choi-Miura NH, Wisniewski HM, Mossakowski MJ (1995) Complete cerebral ischemia with short term survival in rat induced by cardiac arrest: extracellular and intracellular accumulation of apolipoprotein E and J in brain. Brain Res 674:341-346
38. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M (1995) Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 15:1280-1286
39. Laskowitz DT, Goel S, Bennett ER, Matthew WD (1997a) Apolipoprotein E suppresses glial cell secretion of TNFα. J Neuroimmunol 76:70-74
40. Laskowitz DT, Sheng H, Bart R, Joyner K, Roses AD, Warner D (1997b) Apolipoprotein E deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 17: 753-758
41. Macy M, Okano Y, Cardin AD, Avila EM, Harmony JA (1983) Suppression of lymphocyte activation by plasma lipoproteins. Cancer Res 43:2496s-2502s
42. Majack RA, Castle CK, Goodman LV, Weisgraber KH, Mahley RW, Shooter EM, Gebicke-Haerter PJ (1988) Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol 107:1207-1213
43. Masliah E, Mallory M, Alford M, Veinbergs I, Roses AD (1996) Apolipoprotein E: role in maintaining the integrity of the aging nervous system. In: Apolipoprotein E and Alzheimer's Disease (Roses AD, Weisgraber KH, Christen Y. eds), Berlin, Springer Verlag, pp 59-73
44. Masliah E, Samuel W, Veinbergs I, Mallory M, Mante M, Saitoh T (1997) Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res 751:307-314
45. Matthews RT, Beal MF (1996) Increased 3-nitrotyrosine in brains of Apo E-deficient mice. Brain Res 718:181-184
46. Miyata M, Smith JD (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14:55-61
47. Muller HW, Gebicke-Harter PJ, Hangen DH, Shooter EM (1985) A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science 228:499-501
48. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852
49. Newman MF, Croughwell ND, Blumenthall JA, Lowry E, White WD, Spillane W, Davis RD, Glower DD, Smith LR, Mahanna EP (1995) Predictors of cardiac decline after cardiac operation. Ann Thorac Surg 59:1326-1330
50. Nicoll JAR, Roberts GW, Graham DI (1995) Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med 1:135-137
51. Nicoll JAR, Burnett C, Love S, Graham DI, Ironside JW, Vinters HV (1996) High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 39:682-683
52. Nicoll JAR, Horsburgh K, Graham DI (1997) Increased neuronal apoE immunoreactivity after acute brain injury due to hypoxia/ ischaemia, hypoglycaemia, and status epilepticus (Abstr). 4th International Neurotrauma Symposium, August 23-28, 1997, P 1-7
53. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL (1994) ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb 14:605-616
54. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J (1992) Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 23:1556-15562
55. Pepe MG, Curtiss LK (1986) Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In. J Immunol 136:3716-3723
56. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89:4471-4475
57. Poirier J, Hess M, May PC, Finch CE (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res 11:97-106
58. Poirier J, Baccichet A, Dea D, Gauthier S (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55:81-90
59. Rajavashisth TB, Kaptein JS, Reue KL, Lusis AJ (1985) Evolution of apolipoprotein E: mouse sequence and evidence for an 11-nucleotide ancestral unit. Proc Natl Acad Sci USA 82:8035-8089
60. Rogers J, Webster S, Lue LF, Brachova L, Civin WH, Emmerling M, Shivers B, Walker D, McGeer P (1996) Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 17:681-686
61. Roses AD, Saunders AM, Corder EH, Risch NJ, Haines JL, Pericak-Vance MA, Han SH, Einstein G, Hulette C, Schmechel DE, Goedert M, Jakes R, Dong LM, Weisgraber KH, Holsti M, Huang D, Strittmatter W (1995) Apolipoprotein E and Alzheimer's disease. In: Research Advances in Alzheimer's Disease and Related Disorders (Iqbal K, Mortimer JA, Winblad B, Wisniewski HM, eds), London, John Wiley & Sons, pp 85-96.
62. Roses AD (1995) On the metabolism of apolipoprotein E and the Alzheimer diseases. Exp Neurol 132:149-56
63. Roses AD (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med 47:387-400
64. Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD (1994) Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils: isoform apoE4 associates more efficiently than apoE3. J Clin Invest 94:860-9
65. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43:1467-1472
66. Seliger G, Lichtman SW, Polsky T, Riley J, Haverstraw W, Tycko B, Marder K (1997) The effect of apolipoprotein E on short term recovery from head injury (Abstr). Neurology 48:A213
67. Sheng H, Laskowitz DT, Bennett ER, Schmechel DE, Bart RD, Saunders AM, Pearlstein RD, Roses AD, Warner DS (1998) Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab 18:361-366
68. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R (1997) Apolipoprotein E epsilon 4 and the risk of dementia with stroke: a population-based investigation. JAMA 277: 818-821
69. Snipes GJ, McGuire CB, Norden JJ, Freeman JA (1986) Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells. Proc Natl Acad Sci USA 83:1130-1134
70. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease: the nun study. JAMA 277:813-817
71. Sorbi S, Nacmias B, Piacentini S (1996) Apolipoprotein E genotypes and outcome after post-traumatic coma (Abstr). Neurology 46:A307
72. Stoll G, Muller HW (1986) Macrophages in the peripheral nervous system and astroglia in the central nervous system of rat commonly express apolipoprotein E during development but differ in their response to injury. Neurosci Lett 72:233-238
73. Stoll G, Meuller HW, Trapp BD, Griffin JW (1989) Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. Glia 2:170-176
74. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M. Enghild J, Salvesen GS, Roses AD (1993a) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90:1977-1981
75. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993b) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102
76. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD (1994) Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 91:11,183-11,186
77. Tardiff BE, Newman MF, Saunders AM, Strittmatter WJ, Blumenthal JA, White WD, et al. (1997) Preliminary report of a genetic basis for cognitive decline after cardiac operations. Ann Thorac Surg 64:715-720
78. Teasdale GM, Nicoll JAR, Fiddes H, Murray G (1997) Association of apoE polymorphism with outcome after head injury. Lancet 350: 1069-1071
79. Vogel T, Guo NH, Guy R, Drezlich N, Krutzsch HC, Blake DA, Panet A, Roberts DD (1994) Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem 54:299-308
80. Xu P, Schmechel D, Rothrock-Christian T, Burkhart DS, Qiu H, Popko B, Sullivan P. Maeda N. Saunders AM, Roses AD, Gilbert J (1996) Human apolipoprotein E2, E3, and E4 isoform specific transgenic mice: human-like pattern of neuronal immunoreactivity in central nervous system not observed in wildtype mice. Neurobiol Dis 3: 229-245